<DOC>
	<DOCNO>NCT02422056</DOCNO>
	<brief_summary>Randomized study evaluate role tranexamic acid reduce intraoperative bleeding palatoplasty .</brief_summary>
	<brief_title>Acid Tranexamic Effectiveness Reducing Intraoperative Bleeding Palatoplasty</brief_title>
	<detailed_description>Double-blind randomize study compare intraoperative bleeding palatoplasty patient receive tranexamic acid dose 10mg / kg bolus follow continuous infusion 1 mg / kg / h end procedure patient receive placebo similar arrangement . Besides impact volume intraoperative bleeding incidence postoperative wound dehiscence first week incidence oronasal fistulas 1 month evaluate .</detailed_description>
	<mesh_term>Hemorrhage</mesh_term>
	<mesh_term>Cleft Palate</mesh_term>
	<mesh_term>Blood Loss , Surgical</mesh_term>
	<mesh_term>Tranexamic Acid</mesh_term>
	<criteria>Palatoplasty indication patient age presence congenital cleft palate ( without associate cleft lip ) , study hospital Preoperative hemoglobin low 10 mg / dl platelet count le 100,000 / mm3 ; Presence coagulopathy cause know coagulation cascade disorder systemic disease , excessive bleed history previous occasion ; History bleed disorder firstdegree relative ; Use medication may interfere coagulation cascade ( platelet inhibitor anticoagulant ) ; Indication secondary palatoplasty purpose correction oronasal fistula ; Known allergy tranexamic acid .</criteria>
	<gender>All</gender>
	<minimum_age>6 Months</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2015</verification_date>
	<keyword>Cleft Palate</keyword>
	<keyword>Hemorrhage</keyword>
	<keyword>Palatoplasty</keyword>
</DOC>